l-carnitine and kidneys Carnitine metabolic disorders novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney disease treatment Size:100 Softgels Nitric oxide-based multi-synergistic nanomedicine: skin brightning

l-carnitine and kidneys Carnitine metabolic disorders novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney disease treatment Size:100 Softgels Nitric oxide-based multi-synergistic nanomedicine: skin brightning

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer | Journal of Nanobiotechnology | Springer Nature Link

Ferredoxin 1 (FDX1), identified as the central regulatory gene in copper-induced cell death, modulates this process by influencing the TCA cycle, specifically through the regulation of DLAT thioctyl acylation (Tsvetkov et al., 2022)

skin brightning

Size:100 Softgels

While CJC-1295 belongs to the class of GHRH (growth hormone-releasing hormone) analogs and supports signaling responsible for GH release, Ipamorelin acts as a selective agonist of the ghrelin receptor (GHS-R), stimulating the pituitary gland through a separate regulatory pathway